Cargando…
Restrictions on the use of placebo in new COVID-19 vaccine trials
Autor principal: | Bonati, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404758/ https://www.ncbi.nlm.nih.gov/pubmed/34462794 http://dx.doi.org/10.1007/s00228-021-03203-z |
Ejemplares similares
-
Placebo control group in COVID-19 vaccine trials: context and timing matters
por: Dal-Ré, Rafael
Publicado: (2021) -
The importance of influenza vaccination during the COVID‐19 pandemic
por: McCauley, John, et al.
Publicado: (2021) -
Calling for an exponential escalation scheme in vaccine development for COVID-19
por: Wehling, Martin
Publicado: (2020) -
COVID-19 and geriatric clinical trials research
por: Rhodus, Elizabeth K., et al.
Publicado: (2020) -
The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis
por: Klamer, T. A., et al.
Publicado: (2022)